Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.

Share:
More In Science
Paying to Sponsor an Ocean
A small island in the Pacific is offering people the chance to help protect its waters by becoming a sponsor of the ocean.
Load More